Avery Brown, MD
LONG BEACH, Calif.—Sleeve gastrectomy patients who undergo conversion to Roux-en-Y gastric bypass experience a greater level of sustained, long-term weight loss and diabetes control than their counterparts who convert to adjuvant glucagon-like peptide-1 receptor agonists, according to the results of a new multicenter retrospective study.
However, the study found that patients who converted to glucagon-like peptide-1 (GLP-1) receptor agonists still